Literature DB >> 25365073

Fibrosis: ultimate and proximate causes.

Victor J Thannickal, Yong Zhou, Amit Gaggar, Steven R Duncan.   

Abstract

Fibrotic disorders account for an increasing burden of disease-associated morbidity and mortality worldwide. Although numerous risk factors have been recognized, the etiologies of many of these clinical syndromes have not been identified, and they are often termed idiopathic or cryptogenic. Here, we provide an evolutionary perspective on fibrosis aimed at elucidating its etiopathogenesis. By asking the ultimate question of "why" this process evolved in multicellular organisms, we hope to uncover proximate explanations for "how" it causes disease in humans. We posit that physiological fibrosis-like reactions evolved as an essential process in host defense against pathogens and in normal wound healing. Based on this premise, we reason that pathological fibrosis is related to one or more of the following: unidentified infectious or noninfectious antigens, autoimmunity, impaired regenerative responses, and the antagonistically pleiotropic action of genes involved in wound healing or development. The importance of genetic susceptibility, epigenetics, aging, and the modern-day environment are highlighted. Consideration of both ultimate and proximate causation goes beyond philosophical cogitations, as it will better inform pathobiological mechanisms of disease and aid in the prevention and treatment of fibrotic diseases.

Entities:  

Mesh:

Year:  2014        PMID: 25365073      PMCID: PMC4347226          DOI: 10.1172/JCI74368

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  51 in total

Review 1.  The adaptive immune system in diseases of the central nervous system.

Authors:  David C Wraith; Lindsay B Nicholson
Journal:  J Clin Invest       Date:  2012-04-02       Impact factor: 14.808

2.  Cellular and humoral autoreactivity in idiopathic pulmonary fibrosis.

Authors:  Carol A Feghali-Bostwick; Christopher G Tsai; Vincent G Valentine; Stephen Kantrow; Michael W Stoner; Joseph M Pilewski; Aneal Gadgil; M Patricia George; Kevin F Gibson; Augustine M K Choi; Naftali Kaminski; Yingze Zhang; Steven R Duncan
Journal:  J Immunol       Date:  2007-08-15       Impact factor: 5.422

3.  Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis.

Authors:  Yong Zhou; Xiangwei Huang; Louise Hecker; Deepali Kurundkar; Ashish Kurundkar; Hui Liu; Tong-Huan Jin; Leena Desai; Karen Bernard; Victor J Thannickal
Journal:  J Clin Invest       Date:  2013-02-22       Impact factor: 14.808

4.  Incidence and prevalence of idiopathic pulmonary fibrosis.

Authors:  Ganesh Raghu; Derek Weycker; John Edelsberg; Williamson Z Bradford; Gerry Oster
Journal:  Am J Respir Crit Care Med       Date:  2006-06-29       Impact factor: 21.405

5.  Aging, antagonistic pleiotropy and fibrotic disease.

Authors:  Victor J Thannickal
Journal:  Int J Biochem Cell Biol       Date:  2010-06-04       Impact factor: 5.085

6.  Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice.

Authors:  Yan Y Sanders; James S Hagood; Hui Liu; Wei Zhang; Namasivayam Ambalavanan; Victor J Thannickal
Journal:  Eur Respir J       Date:  2014-03-06       Impact factor: 16.671

7.  Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis.

Authors:  Marco Chilosi; Venerino Poletti; Alberto Zamò; Maurizio Lestani; Licia Montagna; Paola Piccoli; Serena Pedron; Manuela Bertaso; Aldo Scarpa; Bruno Murer; Alessandra Cancellieri; Roberta Maestro; Gianpietro Semenzato; Claudio Doglioni
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

8.  Plasma B lymphocyte stimulator and B cell differentiation in idiopathic pulmonary fibrosis patients.

Authors:  Jianmin Xue; Daniel J Kass; Jessica Bon; Louis Vuga; Jiangning Tan; Eva Csizmadia; Leo Otterbein; Makoto Soejima; Marc C Levesque; Kevin F Gibson; Naftali Kaminski; Joseph M Pilewski; Michael Donahoe; Frank C Sciurba; Steven R Duncan
Journal:  J Immunol       Date:  2013-07-19       Impact factor: 5.422

9.  Antagonistic pleiotropy as a widespread mechanism for the maintenance of polymorphic disease alleles.

Authors:  Ashley J R Carter; Andrew Q Nguyen
Journal:  BMC Med Genet       Date:  2011-12-12       Impact factor: 2.103

Review 10.  Genetic studies provide clues on the pathogenesis of idiopathic pulmonary fibrosis.

Authors:  Jonathan A Kropski; William E Lawson; Lisa R Young; Timothy S Blackwell
Journal:  Dis Model Mech       Date:  2013-01       Impact factor: 5.758

View more
  97 in total

1.  CD70 Activation Decreases Pulmonary Fibroblast Production of Extracellular Matrix Proteins.

Authors:  Thi K Tran-Nguyen; Jianmin Xue; Carol Feghali-Bostwick; Frank C Sciurba; Daniel J Kass; Steven R Duncan
Journal:  Am J Respir Cell Mol Biol       Date:  2020-08       Impact factor: 6.914

2.  Attenuated pulmonary fibrosis in sialidase-3 knockout (Neu3-/-) mice.

Authors:  Tejas R Karhadkar; Wensheng Chen; Richard H Gomer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-10-16       Impact factor: 5.464

3.  miR-34a Inhibits Lung Fibrosis by Inducing Lung Fibroblast Senescence.

Authors:  Huachun Cui; Jing Ge; Na Xie; Sami Banerjee; Yong Zhou; Veena B Antony; Victor J Thannickal; Gang Liu
Journal:  Am J Respir Cell Mol Biol       Date:  2017-02       Impact factor: 6.914

4.  Perivascular cell αv integrins as a target to treat skeletal muscle fibrosis.

Authors:  Pedro H D M Prazeres; Anaelise O M Turquetti; Patrick O Azevedo; Rodrigo S N Barreto; Maria A Miglino; Akiva Mintz; Osvaldo Delbono; Alexander Birbrair
Journal:  Int J Biochem Cell Biol       Date:  2018-04-05       Impact factor: 5.085

5.  Quantification of airway fibrosis in asthma by flow cytometry.

Authors:  Andrew Reichard; Nicholas Wanner; Eric Stuehr; Mario Alemagno; Kelly Weiss; Kimberly Queisser; Serpil Erzurum; Kewal Asosingh
Journal:  Cytometry A       Date:  2018-04-16       Impact factor: 4.355

6.  Tamm-Horsfall Protein Regulates Mononuclear Phagocytes in the Kidney.

Authors:  Radmila Micanovic; Shehnaz Khan; Danielle Janosevic; Maya E Lee; Takashi Hato; Edward F Srour; Seth Winfree; Joydeep Ghosh; Yan Tong; Susan E Rice; Pierre C Dagher; Xue-Ru Wu; Tarek M El-Achkar
Journal:  J Am Soc Nephrol       Date:  2017-11-27       Impact factor: 10.121

7.  Myofibroblast Functions in Tissue Repair and Fibrosis: An Introduction.

Authors:  Victor J Thannickal
Journal:  Methods Mol Biol       Date:  2021

8.  Larger Nephron Size and Nephrosclerosis Predict Progressive CKD and Mortality after Radical Nephrectomy for Tumor and Independent of Kidney Function.

Authors:  Aleksandar Denic; Hisham Elsherbiny; Aidan F Mullan; Bradley C Leibovich; R Houston Thompson; Luisa Ricaurte Archila; Ramya Narasimhan; Walter K Kremers; Mariam P Alexander; John C Lieske; Lilach O Lerman; Andrew D Rule
Journal:  J Am Soc Nephrol       Date:  2020-09-16       Impact factor: 10.121

9.  miR-323a-3p regulates lung fibrosis by targeting multiple profibrotic pathways.

Authors:  Lingyin Ge; David M Habiel; Phil M Hansbro; Richard Y Kim; Sina A Gharib; Jeffery D Edelman; Melanie Königshoff; Tanyalak Parimon; Rena Brauer; Ying Huang; Jenieke Allen; Dianhua Jiang; Adrianne A Kurkciyan; Takako Mizuno; Barry R Stripp; Paul W Noble; Cory M Hogaboam; Peter Chen
Journal:  JCI Insight       Date:  2016-12-08

10.  Glycolytic Reprogramming in Myofibroblast Differentiation and Lung Fibrosis.

Authors:  Na Xie; Zheng Tan; Sami Banerjee; Huachun Cui; Jing Ge; Rui-Ming Liu; Karen Bernard; Victor J Thannickal; Gang Liu
Journal:  Am J Respir Crit Care Med       Date:  2015-12-15       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.